DekaBank Deutsche Girozentrale
CLB icon

DekaBank Deutsche Girozentrale’s Core Laboratories CLB Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-59,000
Closed -$1.61M – 1432
2021
Q3 		$1.61M Buy
59,000
+35,000
+146% +$1.07M ﹤0.01% 776
2021
Q2 		$917K Buy
+24,000
New +$860K ﹤0.01% 932
2019
Q2 		– Sell
-13,500
Closed -$1.55M – 1181
2019
Q1 		$1.55M Buy
+13,500
New +$905K 0.01% 665
2018
Q4 		– Sell
-13,500
Closed -$1.55M – 1192
2018
Q3 		$1.55M Hold
13,500
– – 0.01% 677
2018
Q2 		$1.69M Buy
13,500
+3,500
+35% +$426K 0.01% 625
2018
Q1 		$1.04M Buy
10,000
+4,510
+82% +$499K 0.01% 711
2017
Q4 		$512K Hold
5,490
– – ﹤0.01% 815
2017
Q3 		$512K Sell
5,490
-72
-1% -$6.98K ﹤0.01% 821
2017
Q2 		$579K Buy
5,562
+1,950
+54% +$210K ﹤0.01% 808
2017
Q1 		$427K Buy
3,612
+1,780
+97% +$207K ﹤0.01% 762
2016
Q4 		$218K Sell
1,832
-6,160
-77% -$682K ﹤0.01% 813
2016
Q3 		$886K Sell
7,992
-8,028
-50% -$925K 0.01% 564
2016
Q2 		$1.95M Buy
16,020
+15,100
+1,641% +$1.82M 0.02% 459
2016
Q1 		$103K Sell
920
-10,500
-92% -$1.09M ﹤0.01% 951
2015
Q4 		$1.23M Sell
11,420
-406
-3% -$46.5K 0.01% 540
2015
Q3 		$1.17M Buy
11,826
+9,750
+470% +$1.06M 0.01% 532
2015
Q2 		$240K Sell
2,076
-15,750
-88% -$1.91M ﹤0.01% 845
2015
Q1 		$1.84M Buy
17,826
+2,800
+19% +$298K 0.02% 461
2014
Q4 		$1.85M Buy
15,026
+9,597
+177% +$1.26M 0.02% 467
2014
Q3 		$806K Sell
5,429
-755
-12% -$117K 0.01% 551
2014
Q2 		$1.03M Sell
6,184
-8,752
-59% -$1.56M 0.02% 494
2014
Q1 		$2.99M Buy
14,936
+12,036
+415% +$2.27M 0.05% 330
2013
Q4 		$553K Buy
2,900
+2,600
+867% +$484K 0.01% 533
2013
Q3 		$50K Sell
300
-136
-31% -$21.1K ﹤0.01% 809
2013
Q2 		$67K Buy
+436
New +$61.8K ﹤0.01% 683

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

DekaBank Deutsche Girozentrale's CLB Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 59,000 shares — an estimated $1.61M sold.

DekaBank Deutsche Girozentrale first reported a position in CLB in Q2 2013 and held it in 25 quarters. The position peaked at $2.99M in Q1 2014. 173 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 59,000 Core Laboratories shares in Q4 2021, an estimated $1.61M.
  • DekaBank Deutsche Girozentrale first reported a position in Core Laboratories in Q2 2013 and held it in 25 quarters.
  • DekaBank Deutsche Girozentrale's Core Laboratories position peaked at $2.99M in Q1 2014.
  • 173 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.